1 Hutchison Pharmaceuticals Announces Approval Of Cd73 Monoclonal Antibody Mupadolimab In Phase I/Ib Clinical Trial In China Nov 13, 2024
Read More Apparatus Heavyweight! First ADC Drug For Refractory Ovarian Cancer Receives Accelerated FDA Approval Nov 03, 2024
Read More Disease What Is The Difference Between Laryngeal Cancer And Pharyngitis? What Is The Way To Confirm The Diagnosis Of Laryngeal Cancer? Nov 14, 2024
